Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics

dc.contributor.authorLópez, Abraham
dc.contributor.authorHerranz-Trillo, Fátima
dc.contributor.authorKotev, Martin
dc.contributor.authorGairí, Margarida
dc.contributor.authorGuallar, Víctor
dc.contributor.authorBernadó, Pau
dc.contributor.authorMillet, Oscar
dc.contributor.authorTarragó, Teresa
dc.contributor.authorGiralt, Ernest
dc.contributor.otherBarcelona Supercomputing Center
dc.date.accessioned2017-01-30T15:01:48Z
dc.date.available2017-05-17T00:30:20Z
dc.date.issued2016-05-17
dc.description.abstractDeciphering conformational dynamics is crucial for understanding the biological functions of proteins and for designing compounds targeting them. In particular, providing an accurate description of microsecond–millisecond motions opens the opportunity for regulating protein–protein interactions (PPIs) by modulating the dynamics of one interacting partner. Here we analyzed the conformational dynamics of prolyl oligopeptidase (POP) and the effects of active-site-directed inhibitors on the dynamics. We used an integrated structural biology approach based on NMR spectroscopy and SAXS experiments complemented by MD simulations. We found that POP is in a slow equilibrium in solution between open and closed conformations, and that inhibitors effectively abolished this equilibrium by stabilizing the enzyme in the closed conformation.
dc.description.peerreviewedPeer Reviewed
dc.description.sponsorshipThis work was supported by the Institute for Research in Biomedicine, MINECO-FEDER (Bio2013-40716-R, CTQ2013-48287 and CTQ2012-32183/BQU), and the Generalitat de Catalunya (XRB and Grup Consolidat 2014SGR521). AL has received funding from the Instituto de Salud Carlos III. PB acknowledges the Agence Nationale de la Recherche (SPINHD-ANR-CHEX-2011) and the ATIP-Avenir program for financial support. FHT’s fellowship is co-funded by the INSERM and the University of Copenhagen. Technical assistance from staff at the P12 beam line (EMBL/DESY) is acknowledged.
dc.description.versionPostprint (author's final draft)
dc.format.extent5 p.
dc.identifier.citationLópez, Abraham [et al.]. Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics. "ChemBioChem", 17 Maig 2016, vol. 17, núm. 10, p. 913-917.
dc.identifier.doi10.1002/cbic.201600102
dc.identifier.issn1439-4227
dc.identifier.urihttps://hdl.handle.net/2117/100311
dc.language.isoeng
dc.publisherWiley
dc.relation.projectidinfo:eu-repo/grantAgreement/MINECO//BIO2013-40716-R/ES/PEPTIDOS COMO AGENTES TERAPEUTICOS: MODULACION DE INTERACCIONES PROTEINA-PROTEINA Y TRANSPORTE AL CEREBRO/
dc.relation.projectidinfo:eu-repo/grantAgreement/MINECO//CTQ2013-48287-R/ES/DISENYO COMPUTACIONAL RACIONAL DE OXIDOREDUCTASAS PARA APLICACIONES INDUSTRIALES Y TECNOLOGICAS/
dc.relation.projectidinfo:eu-repo/grantAgreement/MINECO/1PE/CTQ2012-32183/BQU
dc.relation.publisherversionhttp://onlinelibrary.wiley.com/doi/10.1002/cbic.201600102/abstract
dc.rights.accessOpen Access
dc.subjectÀrees temàtiques de la UPC::Enginyeria biomèdica
dc.subject.lcshProteins--Analysis
dc.subject.lemacProteïnes--Anàlisi
dc.subject.otherProtein–protein interactions (PPIs)
dc.subject.otherProlyl oligopeptidase (POP)
dc.titleActive-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics
dc.typeArticle
dspace.entity.typePublication
local.citation.endingPage917
local.citation.number10
local.citation.publicationNameChemBioChem
local.citation.startingPage913
local.citation.volume17

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Active Site-Directed Inhibitors of Prolyl Oligopeptidase.pdf
Mida:
2.23 MB
Format:
Adobe Portable Document Format
Descripció:

Col·leccions